Read the full press release

Aliri has been a pioneer in the development and application of bioanalytical and spatial multi-omics solutions for over 30 years, and we continue to be at the forefront of innovation today.  Our seasoned team of scientists and technical experts provide a broad range of services and solutions that will help you to advance your molecule from discovery through clinical development and approval, while providing unmatched insights to de-risk your program and accelerated timelines to get you to your next milestone faster.

null

Advance your life-saving molecule from non-clinical to clinical with speed and agility

-

BioAnalysis
With patients’ lives on the line, you cannot afford any mistakes within your drug development program. That’s why finding the right bioanalytical lab to get you accurate and timely data will help you successfully file your IND with speed and confidence. We are committed to ensuring that your drug program is scientifically and regulatory compliant across all phases. Read More
null

Gain access to unique data for analysis and decision making

-

Spatial
Spatial bioanalysis and biology are solutions to help generate unique data that will help optimize strategic decisions and understand drug exposure at the site of action and the impact to the microenvironment. Adopting spatial bioanalysis and biology into your strategy early on, can help you save money and time in the long run. Read More

Aliri has the proven operational excellence across a range of traditional and cutting-edge technologies paired with the experience to support the unique needs of your development program.

Learn how you can utilize our team of dedicated scientists, program managers, quality specialists and industry experts.
null

Access quality data for filing your IND, NDA, or CTA with speed

null

Anticipate technical issues or potential roadblocks that may cause delays

null

Elucidate drug efficacy in the pertinent spatial context up to a cellular level, for more efficient and effective drug candidate evaluation and selection

null

Maximize the value of your drug discovery and development investments

131

Audits

16

FDA Audits

5

Samples Analyzed